News >

ctDNA Testing Now Valuable Tool in CRC, Next Steps Underway

Ellie Leick
Published: Monday, Aug 19, 2019

Pashtoon M. Kasi, MBBS, MD, MS, a medical oncologist and assistant professor at the Carver College of Medicine at the University of Iowa

Pashtoon M. Kasi, MBBS, MD, MS

Circulating tumor DNA (ctDNA) detection via liquid biopsy can be used to noninvasively detect biomarkers as well as monitor patients with colorectal cancer (CRC), but more research is needed to determine its optimal role, explained Pashtoon M. Kasi, MBBS, MD, MS.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut AllergySep 28, 20191.0
Enduring CME activity from the School of Breast Oncology®: 2018 Mid-Year Video UpdateSep 28, 20192.0
Publication Bottom Border
Border Publication